Workflow
体检行业规范
icon
Search documents
爱康国宾正式起诉患癌客户 当事人再度回应
Core Viewpoint - The ongoing controversy surrounding the case of lawyer Zhang Xiaoling, who claims that Aikang Guobin failed to detect her cancer risk during ten years of health check-ups, has led to a formal lawsuit filed by Aikang Group against her [1][2]. Group 1: Company Response - Aikang Group held a media briefing to clarify that there were no flaws in Zhang's kidney examinations and denied any allegations of misdiagnosis or "fake health checks" [1][2]. - The company has initiated legal proceedings against Zhang Xiaoling, which have been accepted by the court, and they expect a fair judgment [2][6]. - Aikang Group's management emphasized that the health check reports were consistent with the actual ultrasound findings and that there was no misdiagnosis [4][6]. Group 2: Zhang Xiaoling's Claims - Zhang Xiaoling asserts that despite ten years of annual health checks, she was never warned about any cancer risks until a report in October 2023 indicated potential issues with her kidneys [2][3]. - She recalls being told by Aikang's doctors that her kidney issues were not concerning and that she would be contacted if there were any problems, which she claims never happened [3][5]. - After switching to a different medical institution, she was diagnosed with advanced kidney cancer, which she attributes to Aikang's failure to detect her condition earlier [4][5]. Group 3: Industry Implications - The case has raised questions about the operational standards and diagnostic accuracy within the health check industry, prompting Zhang to call for greater transparency and accountability [6][7]. - Zhang plans to collaborate with legal and medical professionals to address issues of misdiagnosis and negligence in health checks, aiming to initiate a public interest lawsuit to improve industry regulations [6][7].
体检生意不能变成糊涂账
Bei Jing Shang Bao· 2025-07-31 17:28
Core Viewpoint - The health check industry is facing significant scrutiny due to consumer concerns about the effectiveness of cancer risk detection, leading to potential legal actions from health check institutions against allegations of misinformation [1] Group 1: Industry Challenges - The health check business is sensitive and closely tied to life and health, prompting consumers to question its efficacy and institutions to defend their reputations [1] - A recent media briefing intended to clarify misunderstandings instead escalated into a secondary public relations crisis due to unclear communication from executives [2] - The core value of health checks lies in screening and early warning, not in diagnosis and treatment, which needs to be clearly communicated to consumers [2] Group 2: Pricing and Value Discrepancies - There is a persistent divide between health check institutions and consumers regarding the perceived value of services, exacerbated by low-cost packages that raise doubts about their effectiveness [2] - The industry must address the mismatch between price and value, ensuring that the quality of testing correlates with the cost, and that high-end packages deliver tangible benefits [2][3] - Transparency and openness in operations are essential to avoid confusion in the health check business, with a need for institutions to clearly outline costs, profits, and expected outcomes for consumers [3] Group 3: Market Dynamics - The growth of private health check institutions is a response to the inability of public hospitals to meet the high demand, creating both opportunities and pressures within the market [3] - The resolution of the current chaotic situation in the industry relies on self-regulation by companies, public oversight, enhanced regulation, and increased market competition [3]